FDA — authorised 23 May 2018
- Application: ANDA206164
- Marketing authorisation holder: ENCUBE
- Status: approved
FDA authorised Benzoyl Peroxide gel on 23 May 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 23 May 2018; FDA authorised it on 25 May 2018.
ENCUBE holds the US marketing authorisation.